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Case report Circulating cytokines and procalcitonin in acute Q 
fever granulomatous hepatitis with poor response 
to antibiotic and short-course steroid therapy: a 
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Abstract
Background: Q fever is a zoonosis distributed worldwide that is caused by Coxiella burnetii infection and the 
defervescence usually occurs within few days of appropriate antibiotic therapy. Whether the changes of cytokine levels 
are associated with acute Q fever with persistent fever despite antibiotic therapy had not been investigated before.
Case Presentation: We report a rare case of acute Q fever granulomatous hepatitis remained pyrexia despite several 
antibiotic therapy and 6-day course of oral prednisolone. During the 18-month follow-up, the investigation of the 
serum cytokines profile and procalcitonin (PCT) revealed that initially elevated levels of interleukin-2 (IL-2), IL-8, IL-10, 
and PCT decreased gradually, but the IL-6 remained in low titer. No evidence of chronic Q fever was identified by 
examinations of serum antibodies against C. burnetii and echocardiography.
Conclusions: The changes of cytokine levels may be associated with acute Q fever with poor response to treatment 
and PCT may be an indicator for monitoring the response to treatment.
Background
Q fever is a zoonosis distributed worldwide that is caused
by  Coxiella burnetii infection [1]. The major clinical
manifestations of symptomatic acute Q fever are influ-
enza-like illness with various degrees of pneumonia or
hepatitis [1]. Defervescence usually occurs several days
after the administration of antibiotics that are effective
against C. burnetii. However, cases of acute Q fever with
poor response to antimicrobial therapy that demand a
combination therapy with steroids have been reported [2-
4]. Development of autoantibodies that induce inflamma-
tory or immunologic processes is presumed to be respon-
sible for persistent fever [1-4]. Whether the changes of
cyt o k i n e  l ev e l s  a r e  a s s oc i a t e d  wi t h  a c u t e  Q  f ev e r  wi t h
persistent fever despite antibiotic therapy had not been
investigated before. Herein, we report a case of acute Q
fever granulomatous hepatitis with poor response to anti-
biotic and short-course steroid therapy, and we present
the changes in the profile of circulating cytokines and
procalcitonin (PCT), which was identified in a study con-
ducted to investigate cytokine profiles in patients with Q
fever.
Case Presentation
A 35-year-old male was admitted because of a 7-day his-
tory of fever with chills. He was a truck driver and worked
in southern T aiwan. He recalled a history of visiting his
father, who bred hundreds of goats, about 3 weeks prior
admission, but the patient denied direct contact with or
close proximity to the goats.
Upon admission, the patient's body temperature was
39.7°C, his heart rate was 88 beats/min, and his blood
pressure was 140/70 mmHg. No abnormality was
revealed by physical examination. The laboratory exami-
nations revealed a white blood cell (WBC) count of
10,450/mm3 (neutrophils, 76%; lymphocytes, 16%; mono-
cytes, 5%), a hemoglobin level of 12.7 g/dl, a platelet
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count of 324,000/mm3, an alanine aminotransferase
(ALT) level of 145 U/L (reference range, 0-44 U/L), an
aspartate aminotransferase (AST) level of 76 U/L (refer-
ence range, 0-38 U/L), a total bilirubin level of 0.9 mg/dl
(reference, 0-1.3 mg/dl), and a serum creatinine level of
1.1 mg/dl. No abnormality was found by chest x-ray or
urine analysis. Abdominal ultrasonography revealed
hepatosplenomegaly, a moderately fatty liver, and a thick-
ened gallbladder wall. Acute Q fever was highly sus-
pected clinically, and oral doxycycline, 100 mg every 12
hours, was administered empirically. However, the fever
persisted despite 4 days of treatment of doxycycline; thus,
intravenous levofloxacin, 500 mg per day, was added
starting at day 5. Abdominal computed tomography (CT)
revealed multiple periaortic reactive lymph nodes, mes-
entery infiltration, and hepatomegaly. Neither mediasti-
nal lymph nodes nor pulmonary lesion was found by
chest CT. No focus of inflammation was found by Gal-
lium inflammation scan. Oral prednisolone at a dosing
schedule of 40 mg daily, 20 mg daily, and then 10 mg daily
for 2 days each was administered from days 7 to 12. The
first blood specimen collected on day 1 was sent to the
Taiwan CDC for Q fever testing, and the results of the
antibody assay and the polymerase chain reaction for C.
burnetii were all reported to be negative on day 8.
No bacterial growth was found by blood and urine cul-
tures. The results of the serum HBsAg, anti-HBc IgM,
anti-HAV IgM, anti-HCV, anti-nuclear antibody, IgM
antibodies against Epstein-Barr virus and Cytomegalovi-
rus, anti-HIV, and VDRL tests were all negative. The thy-
roid function, serum cortisol level, and tumor markers
including PSA, AFP, CEA, and Ca-199 were all within
normal limits. Other antibiotics including azithromycin
and ceftriaxones were administered later due to persis-
tent fever. Because of the refractory spiking fever, hepato-
megaly, elevated liver enzymes, and no identified
infection source or pathogen, a sono-guided fine-needle
liver biopsy was performed on day-13 (Figure 1). The
pathological finding revealed granulomatous inflamma-
tion of the liver without the characteristic "doughnut
granulomas" of Q fever. Neither acid-fast microorganisms
nor fungus was found. No mycobacterium, fungus, or
other bacterium was isolated from the tissue culture.
Because tuberculosis (TB) is an endemic disease in south-
ern Taiwan and is a common cause of granulomatous
hepatitis, a therapeutic trial of four combined anti-TB
drugs was added starting at day 15. Steroid therapy with
intravenous methylprednisolone, 20 mg every 12 hours,
was added 2 days later. On day 19, however, the Q fever
analysis of serum collected on day 12 (19th day from dis-
ease onset) revealed anti-phase II IgM = 1:1600 and anti-
phase II IgG = 1:6400 (Figure 2A). At this time, the anti-
TB drugs were suspended. The fever subsided, and the
steroid was shifted to oral prednisolone and was tapered
gradually. The patient was discharged on day 26 with
prednisolone, 10 mg daily for 3 days. The patient was fol-
lowed, and no evidence of development of chronic Q
fever infective endocarditis was found by Q fever serolog-
ical tests and echocardiography (Figure 2B).
Among the 11 tested cytokines, only IL-2, IL-6, IL-8,
and IL-10 were detectable from disease onset to the 18-
month follow-up. The levels of IL-2, IL-8, and IL-10 were
elevated initially and decreased gradually, but the IL-6
level remained low (Figure 2C). The initial elevated PCT
level also decreased with time (Figure 2D).
The study and the patient
This study was approved by the Ethics Committee of the
E-Da Hospital (EMRP-097-117). Signed informed con-
sent was obtained from the patient before clinical obser-
vation and blood collection.
Serologic assessments for specific antibodies against C. 
burnetii
Indirect immunofluorescence antibody assays (IFA) were
performed for serologic assessment of specific antibodies
against  C. burnetii using commercially available kits
(Focus Diagnostics Q Fever IFA IgG and IgM assay).
Measurement of serum cytokines
The serum was separated from the blood within 2 hours
after collection and was stored at -80°C until analysis.
Eleven cytokines were tested simultaneously, including
interferon-γ (INF-γ), interleukin-1β (IL-1β), IL-2, IL-4,
IL-5, IL-6, IL-8, IL-10, IL-12 p70, tumor necrosis factor-α
(TNF-α), and TNF-β using a multiplex cytokine kit
(Human Th1/Th2 11plex FlowCytomix Multiplex
[BMS810FF], Bender MedSystems™) and a BD FACSCali-
bur™ flow cytometer (Becton, Dickinson and Company)
in accordance with the manufacturer's instructions. All
assays were performed in duplicate.
Measurement of serum procalcitonin (PCT)
Measurement of the serum PCT concentration was per-
formed using VIDAS® B·R·A·H·M·S PCT tests.
Conclusions
Geographic differences are found between Q fever pneu-
monia and hepatitis [1], and the latter is predominant in
Taiwan [5,6]. Cases of acute Q fever presenting with
granulomatous hepatitis and persistent fever in spite of
antimicrobial therapy that demanded combination ther-
apy with steroids have been reported [2-4]. Among these
reported cases, defervescence was usually achieved
within a few days of initiation of steroid therapy (20-30
mg prednisolone/day) [2-4]. Immunologic and inflamma-
tory process related fever due to development of autoan-
tibodies were presumed responsible for the persistent
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a combination with a 6-day course of prednisolone when
apyrexia was not obtained after 3 days of antibiotic ther-
apy [1]. However, our patient did not defervesce until
administration of intravenous methylprednisolone
despite administration of a 6-day course of oral predniso-
lone. This indicates that the immunological response to
C. burnetii infection in our patient might have been
stronger, this requiring a higher dosage and a longer
course of steroids to defervesce.
Previous studies investigating the cytokines involved in
acute Q fever primarily focused on comparing patients
with controls or those with different presentations, not
on the response to treatment [7,8]. The circulating TNF
and IL-6 levels were markedly increased in patients with
acute Q fever compared with controls [7]. In the study of
peripheral blood mononuclear cells (PBMCs) collected
from acute Q fever patients, the production of TNF, IL-6,
IL-12, and IL-10 was higher than in control subjects, and
TNF and IL-10 levels were higher in patients with hepati-
tis than in those with isolated fever [8]. Induction of fever
involves a multiple-pathway mechanism in which circu-
lating cytokines, particularly proinflammatory cytokines
including TNF, IL-1, IL-6, and INF, are the major media-
tors of fever [9]. However, only IL-2, IL-6, IL-8, and IL-10
were detectable in the serum of our patient (Figure 2C).
Interleukin-2 is thought to induce fever through induc-
tion of IL-1 and TNF [9], and the persistent elevation of
IL-2 might partially explain the difficulty in deferves-
cence in our patient. Interleukin-6 has been proposed to
be a mediator of fever downstream of IL-1 and TNF [9],
but IL-6 persisted at a low level irrespective of fever in
our patient. This result might reflect the undetectable
serum levels of IL-1 and TNF. The fact that proinflamma-
tory cytokines in our patient were undetectable might
due to the inhibitory effect of an anti-inflammatory
cytokine, IL-10, which was persistently elevated during
the first month of illness and became undetectable 18
months later. Interleukin-8 and PCT are biomarkers used
for predicting the severity of sepsis and mortality [10,11],
but their kinetic change had not been investigated previ-
ously in acute Q fever patients. We found the initial level
of PCT was increased (1.0 ng/ml) (< 0.05 ng/ml in health
people), and it decreased gradually, as did the level of IL-
8. Nevertheless, it must be remembered that the cytokine
levels in the central nervous system rather than the circu-
lating cytokine levels might be responsible for the persis-
tent fever, which could explain why only a few cytokines
were detected in the serum.
In conclusion, this case highlights the difficulty in treat-
ing acute Q fever when the patient responds poorly to
standard antibiotic therapy. Cytokines might be associ-
ated with the persistence of fever in patients without
Figure 1 Body temperature, heart rate, examinations, and treatment during the whole course of hospitalization. The black bars indicate the 
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defervescence despite antibiotic treatment. Procalcitonin
might be used as an indicator for monitoring the
response to treatment.
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